Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Exelixis Stock (NASDAQ: EXEL) stock price, news, charts, stock research, profile.
Open | $26.50 |
Close | - |
Volume / Avg. | 226.24K / 1.84M |
Day Range | $26.28 - $26.50 |
52 Wk Range | 18.64 - 27.83 |
Market Cap | $7.71B |
P/E Ratio | 22.77 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 5.52% |
Days to Cover | 7.65 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Exelixis (NASDAQ:EXEL) through any online brokerage.
Other companies in Exelixis’s space includes: Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Exact Sciences (NASDAQ:EXAS) and Sarepta Therapeutics (NASDAQ:SRPT).
Exelixis has a consensus price target of $27.88.
The stock price for Exelixis (NASDAQ: EXEL) is $26.46 last updated September 23, 2024 at 11:14 AM EDT.
There are no upcoming dividends for Exelixis.
Exelixis’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
There is no upcoming split for Exelixis.
Exelixis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.